TABLE 3.
Multiple logistic regression models
| Experienced delay (Yes = 1, No = 0) | Access to pain relief medicine since the start of COVID‐19 (Yes = 1, No = 0) | Access to other prescription medicine since the start of COVID‐19 (Yes = 1, No = 0) | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | OR | 95% CI | |
| Gender (ref. Male) | 1.06 | 0.52‐2.17 | 0.76 | 0.38‐1.52 | 0.76 | 0.38‐1.51 |
| Age (ref. 60 years and above) | P < .05 | |||||
| 18‐39 | 2.31 | 0.90‐5.94 | 0.42 | 0.16‐1.09 | 0.81 | 0.32‐2.04 |
| 40‐59 | 1.98 | 0.85‐4.61 | 0.35 | 0.15‐0.83 | 0.42 | 0.18‐0.94 |
| College (ref. Some college or higher) | 0.22 | 0.10‐0.46 | 0.88 | 0.43‐1.8 | 1.13 | 0.57‐2.26 |
| Ability to travel limited by curfews or county lockdowns (ref. Yes) | 2.01 | 1.09‐3.69 | 2.19 | 1.19‐4.02 | ||
| Ability to access hospital (ref. Yes) | 14.90 | 7.44‐29.85 | ||||
| Treatment Phase (ref. Completed treatment) | P < .05 | |||||
| Diagnosis or treatment planning | 2.65 | 1.003‐7.01 | 0.92 | 0.37‐2.31 | 1.01 | 0.41‐2.52 |
| Receiving treatment | 1.05 | 0.51‐2.15 | 2.14 | 1.11‐4.13 | 1.91 | 0.99‐3.69 |
| Travel time to Nairobi (in hours) | 1.20 | 1.06‐1.36 | 0.91 | 0.82‐1.01 | 0.99 | 0.89‐1.10 |
| χ2 test (Model Significance) | X 2 (df 8) = 113.48, P < .001 | X 2 (df 8) = 24.15, P < .005 | X 2 (df 8) = 21.77, P < .005 | |||
| Classification without IVs (percent correct) | 55.6% | 64.4% | 62.1% | |||
| Classification with all IVs (percent correct) | 80.3% | 67.1% | 64.9% | |||
| Nagelkerke R 2 | .48 | .15 | .13 | |||
| Cox and Snell R 2 | .36 | .11 | .10 | |||
| Hosmer and Lemeshow Test | X2 (df 8) = 3.45, P = .90 | X2 (df 8) = 4.24, P = .84 | X2 (df 8) = 5.22, P = .73 | |||
Note: Ability to access hospitals and ability to travel are highly correlated variables and therefore both were not included in all multiple regression models.
All values in bold are significant at p < .05.